NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES - Trademark Details
Status: 645 - Final Refusal - Mailed
Serial Number
88730797
Word Mark
NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES
Status
645 - Final Refusal - Mailed
Status Date
2021-09-03
Filing Date
2019-12-17
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
O10
Employee Name
OAKES, JEFFREY ALLEN
Statements
Goods and Services
Pharmaceuticals for the treatment of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease
Goods and Services
Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine
Pseudo Mark
NUCLEAR DELIVERED ANTI BODY DRUG CONJUGATES
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-12-20
Primary Code
042
First Use Anywhere Date
2020-01-10
First Use In Commerce Date
2020-01-10
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Susanna P. Lichter
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2019-12-20 | NEW APPLICATION ENTERED IN TRAM |
| 2019-12-20 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-03-16 | ASSIGNED TO EXAMINER |
| 2020-03-17 | NON-FINAL ACTION WRITTEN |
| 2020-03-17 | NON-FINAL ACTION E-MAILED |
| 2020-03-17 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-04-01 | TEAS AMENDMENT OF USE RECEIVED |
| 2020-04-02 | USE AMENDMENT FILED |
| 2020-04-02 | AMENDMENT TO USE PROCESSING COMPLETE |
| 2020-04-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-04-01 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-04-02 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-04-12 | USE AMENDMENT ACCEPTED |
| 2020-04-13 | NON-FINAL ACTION WRITTEN |
| 2020-04-13 | NON-FINAL ACTION E-MAILED |
| 2020-04-13 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-04-14 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| 2020-10-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-01-22 | ASSIGNED TO LIE |
| 2021-01-25 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-01-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-02-10 | NON-FINAL ACTION WRITTEN |
| 2021-02-10 | NON-FINAL ACTION E-MAILED |
| 2021-02-10 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-08-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-08-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-08-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-09-03 | FINAL REFUSAL WRITTEN |
| 2021-09-03 | FINAL REFUSAL E-MAILED |
| 2021-09-03 | NOTIFICATION OF FINAL REFUSAL EMAILED |
